ImmuneBridge has filed a notice of an exempt offering of securities to raise $12,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, ImmuneBridge is raising $12,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Peretz Partensky played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About ImmuneBridge
ImmuneBridge is on a mission to discover and amplify the cures within us. We are a team of scientists and engineers based in the San Francisco Bay Area. We value curiosity, diversity, humility, and generosity–in life and at work. We founded ImmuneBridge in 2018 because we believe cell therapies are the future of medicine and we have a responsibility to make those therapies available to everyone.
To learn more about ImmuneBridge, visit http://www.immunebridge.com/
Contact:
Peretz Partensky, Chief Executive Officer
415-624-6411
https://www.linkedin.com/in/peretzpartensky/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.